Enterprise Therapeutics to raise £26M series B with Panakes Partners, Versant Ventures, Novartis Venture Fund, IP Group, Forbion Capital, Epidarex Capital

Health services Manufacturing Pharma

Investments

04 January 2024

Enterprise Therapeutics (company)

Health services Manufacturing Pharma

Total investments received (USD): 33.05m

Round value (USD): 33.05m

Round investors: Epidarex Capital Forbion Capital Partners IP Group Novartis Venture Fund Panakès Partners Versant Ventures

Industry: Health services Manufacturing Pharma

Beauty Ecommerce Health services Mobile Pharma

Investments 16 June 2024

Biotech Health services Pharma

Investments 13 June 2024

Biotech Health services Manufacturing

Investments 07 April 2024

Biotech Health services Pharma

Investments 07 April 2024

Biotech Health services Manufacturing

Investments 05 March 2024